Enron Mail

From:scott.sefton@enron.com
To:paul.simons@enron.com
Subject:Re: SFA Update: Who can we trade derivatives with?
Cc:
Bcc:
Date:Fri, 9 Jul 1999 06:23:00 -0700 (PDT)

This is excellent -- please put a copy in our SFA compliance file. Thanks!




Paul Simons
08/07/99 14:03
To: ECT London
cc: (bcc: Scott Sefton/LON/ECT)
Subject: SFA Update: Who can we trade derivatives with?

This month we are going to look briefly at the types of counterparty with
which we can trade derivatives in (or from) the UK under SFA (and CFTC)
rules, and at the principle of selling to them only products which are
"suitable".

Eligible Counterparties

All derivatives trading in the UK (as you know) must be conducted through
Enron Europe Finance & Trading Limited, ("EEFT"), which always acts as
agent. EEFT may arrange derivatives transactions only with "eligible"
counterparties.

In general, an "eligible counterparty" is either:

(i) an investment bank that is regulated by SFA (such as Bankers Trust or
Morgan Stanley) or an overseas dealer in commodity derivatives authorised by
its local regulator; or

(ii) a company that has (or whose holding company has) total assets in excess
of $10,000,000 (approximately o6,500,000); and either

(a) 20 or more shareholders and a paid up share capital or net assets of at
least o500,000; or

(b) fewer than 20 shareholders and a paid up share capital or net assets of
at least o5,000,000.

Other types of entity may qualify as an "eligible" counterparty, but please
consult with the Legal Department in these cases.

Suitability Requirements

In addition to the above, each EEFT Registered Representative should
understand and apply the customer suitability principles that have been
adopted by ECT. These principles require that Registered Representatives only
offer products which are suitable for each counterparty, taking into account
its level of expertise and the use which the product serve. This means that
in the case of less sophisticated counterparties or more complex/exotic
products (or both) extra caution needs to be exercised. It is also essential
in all cases that no misleading statements are made (orally or in
writing).

Best regards

Paul